Molecular docking analyses on the chemical profile and antioxidant potential of Cakile maritima using GC–MS and HPLC
Scientific Reports,
Journal Year:
2025,
Volume and Issue:
15(1)
Published: April 8, 2025
Language: Английский
Inhibitory effects of corylin derived from aerial part of Pueraria lobata on melanin synthesis and potential applications in skin whitening and photoaging management
BoYoon Chang,
No information about this author
SungYeon Kim
No information about this author
Natural Products and Bioprospecting,
Journal Year:
2025,
Volume and Issue:
15(1)
Published: April 27, 2025
Abstract
Purpose
This
study
aimed
to
investigate
the
potential
of
corylin,
a
bioactive
compound
isolated
from
aerial
part
Pueraria
lobata
,
as
novel
skin-whitening
agent.
Specifically,
research
sought
evaluate
its
effects
on
melanin
synthesis,
understand
underlying
mechanisms,
and
validate
efficacy
in
mitigating
hyperpigmentation.
Methods
Bioactive
was
through
systematic
fractionation
process
involving
activated
carbon
pigment
removal,
sequential
solvent
extraction,
resin-based
chromatography.
It
shown
inhibit
synthesis
by
targeting
tyrosinase
activation
modulating
key
signaling
pathways.
Its
reducing
production
validated
cellular
assays
UVB-stimulated
3D
human
skin
model,
highlighting
Results
Through
fractionation,
identified
which
reduced
content
activity
without
cytotoxicity,
modulated
pathways
downregulate
MITF
melanogenic
enzymes,
inhibited
α-glucosidase,
disrupted
glycosylation.
In
it
effectively
decreased
production,
confirming
mitigate
Conclusion
Corylin
is
promising
candidate
for
applications,
hyperpigmentation
multiple
stages
including
enzymatic
regulatory
Further
clinical
studies
are
needed
confirm
safety
therapeutic
dermatological
use.
Graphical
Language: Английский
Innovative nanocarrier systems for enhanced delivery of phyto-active compounds in cancer therapy
Nanomedicine,
Journal Year:
2024,
Volume and Issue:
unknown, P. 1 - 26
Published: Dec. 20, 2024
Millions
of
people
worldwide
suffer
from
cancer,
facing
challenges
such
as
treatments
affecting
healthy
cells,
suboptimal
responses,
adverse
effects,
recurrence
risk,
drug
resistance,
and
nonspecific
targeting.
Chemoresistance
leads
to
fatalities,
but
phytoactives
show
promise
in
cancer
management
despite
limitations
high
metabolism,
poor
absorption,
dosage
requirements.
Challenges
the
large-scale
isolation
phytoactive
compounds,
solubility,
bioavailability,
targeting
limit
their
development.
Recent
developments,
including
carbohydrate,
lipid,
protein-based
nanoparticles,
have
enhanced
treatment
by
improving
bioavailability
targeted
delivery
polyphenols,
alkaloids,
sulfur-containing
flavonoids,
terpenes.
Despite
advancements,
clinical
application
faces
hurdles
inconsistent
immune
responses.
This
article
discusses
phytoactive-loaded
nanoformulations
management,
highlighting
delivery,
unmet
needs,
challenges.
Further
research
is
needed
overcome
these
fully
understand
potential
management.
Language: Английский